Imatinib mesylate inhibits the in vitro formation of erythroid burst-forming units (BFU-Es) in patients with polycythaemia vera

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1412, 2003-01, pp. : 19-19

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evaluation of Epoetin Alpha (rHuEPO) and Darbepoetin Alpha (DARB) on Human Burst-colony Formation (BFU-E) in Culture

By Jamal NM   Krzyzanski W   Cheung W   Lau CY   Messner HA  

The Journal of International Medical Research, Vol. 34, Iss. 1, 2006-01 ,pp. : 42-51

Field House Publishing

Access to resources Recommend Favorite

Imatinib: Emergence of JAK2V617F clone leading to polycythaemia vera, in an elderly patient?: case report

By  

Reactions Weekly, Vol. 1, Iss. 1315, 2010-01 ,pp. : 26-27

Adis International

Access to resources Recommend Favorite

Imatinib mesylate normalised the bone marrow of patients with chronic myeloid leukaemia

By  

Inpharma, Vol. 1, Iss. 1327, 2002-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Imatinib mesylate promising for CML

By  

Inpharma, Vol. 1, Iss. 1303, 2001-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Polycythaemia Vera and Essential Thrombocythaemia: Current Treatment Strategies

By Penninga Elisabeth I.   Bjerrum Ole W.  

Drugs, Vol. 66, Iss. 17, 2006-01 ,pp. : 2173-2187

Adis International

Access to resources Recommend Favorite